4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Medicenna Therapeutics Corp. (MDNA) operates in the Biotechnology industry and is headquartered in Toronto, Canada with about 15 employees. Its market capitalization is roughly C$38 million. In the fiscal year ended 2026-03-31, MDNA reported C$0M in revenue and (C$18M) in net income.
Medicenna Therapeutics Corp., a clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Total Revenue | C$0M | C$0M | C$0M | C$0M |
| Operating Income (EBIT) | (C$22M) | (C$20M) | (C$19M) | (C$16M) |
| Net Income | (C$18M) | (C$12M) | (C$26M) | (C$10M) |
CAD; C$M / C$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| Total Revenue | C$0M | C$0M | C$0M | C$0M | C$0M |
| Operating Income (EBIT) | (C$6M) | (C$6M) | (C$6M) | (C$6M) | (C$6M) |
| Net Income | (C$5M) | (C$4M) | (C$4M) | (C$5M) | (C$5M) |
CAD; C$M / C$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | C$8M | C$28M | C$19M | C$36M | — |
| Total Liabilities | C$6M | C$9M | C$14M | C$7M | — |
CAD; C$M / C$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MDNA viewer.
About TickerBase · Data methodology & sources · Privacy · Terms